Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steen J Bonnema

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Current Opinion in Endocrinology, Diabetes, and Obesity|July 23, 2009
A 30-year perspective on radioiodine therapy of benign nontoxic multinodular goiterSteen J Bonnema, Laszlo Hegedüs
The Journal of Clinical Endocrinology and Metabolism|December 7, 2010
Approach to management of the patient with primary or secondary intrathoracic goiterLaszlo Hegedüs, Steen J Bonnema
Endocrine|February 12, 2017
Calculating the incalculable. Optimal radioiodine dose in Graves' hyperthyroidismLaszlo Hegedüs, Steen J Bonnema
Ugeskrift for Laeger|November 6, 2002
[Gestational diabetes insipidus]Ulla D Hansen, Steen J Bonnema
Endocrine Reviews|February 18, 2003
Management of simple nodular goiter: current status and future perspectivesLaszlo Hegedüs, Steen J Bonnema, Finn N Bennedbaek
European Journal of Endocrinology|April 15, 2004
Long-term effects of radioiodine on thyroid function, size and patient satisfaction in non-toxic diffuse goitreSteen J Bonnema, Viveque E Nielsen, Laszlo Hegedüs
Acta Oncologica (Stockholm, Sweden)|November 23, 2006
Radioiodine therapy in non-toxic multinodular goitre. The possibility of effect-amplification with recombinant human TSH (rhTSH)Steen J Bonnema, Viveque E Nielsen, Laszlo Hegedüs
The Journal of Clinical Endocrinology and Metabolism|January 26, 2006
Transient goiter enlargement after administration of 0.3 mg of recombinant human thyrotropin in patients with benign nontoxic nodular goiter: a randomized, double-blind, crossover trialViveque Egsgaard Nielsen, Steen J Bonnema, Laszlo Hegedüs
European Thyroid Journal|November 16, 2016
Selenium in the Treatment of Thyroid Diseases: An Element in Search of the Relevant Indications?Laszlo Hegedüs, Steen J Bonnema, Kristian H Winther
European Journal of Endocrinology|July 5, 2005
Glucocorticoids do not influence the effect of radioiodine therapy in Graves' diseaseBerit E Jensen, Steen J Bonnema, Laszlo Hegedüs
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Current Opinion in Endocrinology, Diabetes, and Obesity|July 23, 2009
A 30-year perspective on radioiodine therapy of benign nontoxic multinodular goiterSteen J Bonnema, Laszlo Hegedüs
The Journal of Clinical Endocrinology and Metabolism|December 7, 2010
Approach to management of the patient with primary or secondary intrathoracic goiterLaszlo Hegedüs, Steen J Bonnema
Endocrine|February 12, 2017
Calculating the incalculable. Optimal radioiodine dose in Graves' hyperthyroidismLaszlo Hegedüs, Steen J Bonnema
Ugeskrift for Laeger|November 6, 2002
[Gestational diabetes insipidus]Ulla D Hansen, Steen J Bonnema
Endocrine Reviews|February 18, 2003
Management of simple nodular goiter: current status and future perspectivesLaszlo Hegedüs, Steen J Bonnema, Finn N Bennedbaek
European Journal of Endocrinology|April 15, 2004
Long-term effects of radioiodine on thyroid function, size and patient satisfaction in non-toxic diffuse goitreSteen J Bonnema, Viveque E Nielsen, Laszlo Hegedüs
Acta Oncologica (Stockholm, Sweden)|November 23, 2006
Radioiodine therapy in non-toxic multinodular goitre. The possibility of effect-amplification with recombinant human TSH (rhTSH)Steen J Bonnema, Viveque E Nielsen, Laszlo Hegedüs
The Journal of Clinical Endocrinology and Metabolism|January 26, 2006
Transient goiter enlargement after administration of 0.3 mg of recombinant human thyrotropin in patients with benign nontoxic nodular goiter: a randomized, double-blind, crossover trialViveque Egsgaard Nielsen, Steen J Bonnema, Laszlo Hegedüs
European Thyroid Journal|November 16, 2016
Selenium in the Treatment of Thyroid Diseases: An Element in Search of the Relevant Indications?Laszlo Hegedüs, Steen J Bonnema, Kristian H Winther
European Journal of Endocrinology|July 5, 2005
Glucocorticoids do not influence the effect of radioiodine therapy in Graves' diseaseBerit E Jensen, Steen J Bonnema, Laszlo Hegedüs
Pageof 5